Webb25 jan. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a … WebbFind the latest PHIO230421C00002500 (PHIO230421C00002500) stock quote, history, news and other vital information to help you with your stock trading and investing.
Phio Pharmaceuticals (PHIO) Stock Forecast & Price Target
WebbThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … WebbFör 1 dag sedan · Stock Price Forecast According to 7 stock analysts, the average 12-month stock price forecast for PHIO stock is $ 73.44 , which predicts an increase of … sonic the hedgehog robotnik ending
Stock Portfolio & Tracker Yahoo Finance Canada
WebbFind real-time GOOG - Alphabet Inc stock quotes, company profile, news and forecasts from CNN Business. WebbPHIO Stock 12 Months Forecast. $72.00. (1165.24% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Phio Pharmaceuticals in the last 3 months. … WebbPhio Pharmaceuticals Corp. (PHIOW) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 0.0232 +0.0062 (+36.47%) At close: December 21 03:56PM EST … small knee joint effusion and synovitis